GPT Healthcare Limited (NSE: GPTHEALTH, BSE: 544131) is a Kolkata, West Bengal-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹1,182 Cr, it ranks #1,495 by market cap among the 6,197 Indian listed companies on FinBizNet, and #23 of 46 in Hospitals and Healthcare Centers. At ₹143.66 (as of 16 Nov 2026), the share price is 17.9% below its 52-week high of ₹175.00 and 24.9% above its 52-week low of ₹115.00. The share price is down 1.1% over one year and down 7.2% over three months.
| Current Price | ₹143.66 |
|---|---|
| Market Cap | ₹1,182 Cr |
| NSE Symbol | GPTHEALTH |
| BSE Code | 544131 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | 28.2 |
| Return on Equity | 16.32% |
| Return on Assets | 8.60% |
| 52-Week Range | ₹115.00 – ₹175.00 |
| 1-Year Price Change | -1.1% |
| 3-Month Price Change | -7.2% |
| Beta (1Y) | 0.37 |
| Dividend Yield | 2.07% |
| Headquarters | Kolkata, West Bengal |
| Website | ilshospitals.com |
| Revenue | ₹136 Cr |
|---|---|
| Net Profit | ₹15 Cr |
| Net Margin | 11.4% |
| EPS (Basic) | ₹1.88 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
GPT Healthcare Limited reported revenue of ₹136 Cr in Q2 FY27, up 14.1% from ₹119 Cr in Q2 FY26 and up 7.5% from ₹126 Cr in Q1 FY27. It posted a net profit of ₹15 Cr for the quarter, against a net profit of ₹11 Cr in Q2 FY26 (up 45.3%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹101 Cr (Q4 FY25) to ₹136 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q2 FY27 | ₹136 Cr | ₹15 Cr | 11.4% |
| Q1 FY27 | ₹126 Cr | ₹13 Cr | 10.1% |
| Q4 FY26 | ₹126 Cr | ₹15 Cr | 11.5% |
| Q3 FY26 | ₹120 Cr | ₹9 Cr | 7.8% |
| Q2 FY26 | ₹119 Cr | ₹11 Cr | 8.9% |
| Q1 FY26 | ₹107 Cr | ₹8 Cr | 7.2% |
| Q4 FY25 | ₹101 Cr | ₹13 Cr | 12.7% |
Standalone figures (₹ crore, XBRL filings).
Promoters held 65.57% of GPT Healthcare Limited's shares as of Sept 2026, unchanged from Sept 2025. Delivery averaged 59.2% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).
GPT Healthcare Limited owns and operates a chain of multispecialty hospitals under the ILS Hospitals brand name in India. The company offers healthcare services, including internal medicine and diabetology; nephrology, such as renal transplants; laparoscopic and general surgery; gynecology and obstetrics; critical care; gastroenterology; orthopedics and joint replacement; interventional cardiology; neurology; neurosurgery; pediatrics; neonatology; robotic-assisted surgery; bariatric surgery; hematology; psychology; dermatology; and ENT services. It also operates clinics and pharmacies; provides academic and diagnostic services; and sale of pharmaceutical products. The company was incorporated in 1989 and is based in Kolkata, India. GPT Healthcare Limited operates as a subsidiary of GPT Sons Pvt. Ltd.
1. Healthcare Service-This segment offers medical and healthcare services, which includes operation of multidisciplinary private hospitals, clinics, and pharmacies. 2. NA-NA 3. NA-NA 4. NA-NA
1. Healthcare Service-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | ₹1,23,712 Cr | 63 | 21.50% | ₹7,615 Cr | +11.6% |
| Max Healthcare Institute Ltd | ₹91,978 Cr | 63.9 | 14.33% | ₹2,569 Cr | -16.6% |
| Manipal Health Enterprises Ltd | ₹89,110 Cr | 88.4 | — | ₹3,399 Cr | — |
| Aster Dm Healthcare Limited (Asterdm) | ₹63,041 Cr | 97.6 | 10.07% | ₹2,829 Cr | +4.3% |
| Fortis Healthcare Ltd. | ₹58,283 Cr | 55.1 | 11.01% | ₹2,735 Cr | -25.1% |
| Global Health Ltd (Medanta) | ₹38,422 Cr | 69.7 | 15.03% | ₹1,469 Cr | +16.2% |
| Narayana Hrudayalaya Limited | ₹37,907 Cr | 46.2 | 19.85% | ₹2,844 Cr | +2.8% |
| Krishna Institute Of Medical Science (KIMS) | ₹29,056 Cr | 120.6 | 9.72% | ₹1,344 Cr | +0.2% |
| GPT Healthcare Limited | ₹1,182 Cr | 28.2 | 16.32% | ₹136 Cr | -1.1% |
Listed by market capitalisation. Ratios are shown for context only.
GPT Healthcare Limited is trading at ₹143.66, with a market capitalisation of ₹1,182 Cr.
GPT Healthcare Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
GPT Healthcare Limited has a P/E of 28.2 and a return on equity of 16.32%.
GPT Healthcare Limited is listed on the NSE under the symbol GPTHEALTH and on the BSE under the scrip code 544131.
GPT Healthcare Limited's share price is down 1.1% over one year and down 7.2% over three months. Its 52-week range is ₹115.00 to ₹175.00.
In Q2 FY27, GPT Healthcare Limited reported revenue of ₹136 Cr and net profit of ₹15 Cr, with basic EPS of ₹1.88 (standalone, parsed from the company's exchange filing).
GPT Healthcare Limited reported revenue of ₹136 Cr in Q2 FY27, up 14.1% from ₹119 Cr in Q2 FY26 and up 7.5% from ₹126 Cr in Q1 FY27.
Promoters held 65.57% of GPT Healthcare Limited's shares as of Sept 2026, unchanged from Sept 2025.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.